• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.

出版信息

Asia Pac J Clin Oncol. 2023 Dec;19(6):762. doi: 10.1111/ajco.13997. Epub 2023 Oct 27.

DOI:10.1111/ajco.13997
PMID:37888963
Abstract

Retraction: Zhang D, Zhang Y, Sun X. LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1. Asia-Pac J Clin Oncol. 2021;17:253-263. https://doi.org/10.1111/ajco.13451. The above article, published online on 20 October 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal's Editors-in-Chief, Professor Stephen Ackland and Professor Mengzhao Wang, and John Wiley & Sons Australia, Ltd. Following publication, concerns were raised by third parties regarding possible image duplication within Figures 2, 4 and 6. Upon investigation by the editorial team, it was concluded that several image elements of the experimental data were duplicated within figures in the article, or had already been published elsewhere in a different scientific context. Thus, the editors consider the conclusions of this article to no longer be reliable.

摘要

相似文献

1
Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Asia Pac J Clin Oncol. 2023 Dec;19(6):762. doi: 10.1111/ajco.13997. Epub 2023 Oct 27.
2
Retraction.撤回。
Cancer Med. 2024 Jan;13(1):e6713. doi: 10.1002/cam4.6713. Epub 2023 Dec 18.
3
Retraction.撤回。
Cancer Med. 2024 Jan;13(1):e6714. doi: 10.1002/cam4.6714. Epub 2023 Dec 18.
4
Retraction.撤回。
Cancer Med. 2023 May;12(9):11041. doi: 10.1002/cam4.5823. Epub 2023 Apr 12.
5
Retraction statement: Ding, J., Wang, X., Gao, J. and Song, T. (2021), Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio, 11: 2186-2197.撤稿声明:丁,J.,王,X.,高,J. 和宋,T.(2021年),胱抑素SN沉默可消除甲状腺乳头状癌的癌症进展和干细胞特性。《欧洲生物化学学会联合会开放生物学》,11: 2186 - 2197。
FEBS Open Bio. 2023 Aug;13(8):1540. doi: 10.1002/2211-5463.13664. Epub 2023 Jul 6.
6
Retraction.撤回。
Cancer Sci. 2023 Jul;114(7):3057. doi: 10.1111/cas.15809. Epub 2023 May 22.
7
Retraction.撤回。
Cancer Med. 2023 Sep;12(18):19352. doi: 10.1002/cam4.6367. Epub 2023 Sep 19.
8
Retraction: lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway.撤稿声明:长链非编码RNA HOTAIR通过靶向miR-126激活CXCR4和RhoA信号通路促进胃癌增殖和转移。
Cancer Med. 2024 May;13(9):e7220. doi: 10.1002/cam4.7220.
9
RETRACTION: Exosomal miR-106a-5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7-Mediated TRIM24 Degradation.撤稿声明:外泌体miR-106a-5p通过FBXW7介导的TRIM24降解加速鼻咽癌进展。
Cancer Sci. 2024 Nov;115(11):3829. doi: 10.1111/cas.16312. Epub 2024 Aug 21.
10
Retracted: Chen, Y, Zhang, W, Kadier, A, Zhang, H, Yao, X. MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer. J Clin Lab Anal. 2020; 34:e23193.撤回:陈,Y,张,W,卡迪尔,A,张,H,姚,X。MicroRNA-769-5p通过靶向NUSAP1抑制膀胱癌细胞的生长和迁移。《临床实验室分析杂志》。2020年;34:e23193。
J Clin Lab Anal. 2023 Apr;37(8):e24893. doi: 10.1002/jcla.24893. Epub 2023 May 14.